|
||||||||||||||||||||||||||
![]() Lola M. Reid Adjunct Professor, Affiliated Program FacultyProfessor in the Department of Cell and Molecular Physiology Full Member of the Lineberger Cancer Center Full Member of the Center for Gastrointestinal and Biliary Disease Biology (CGIBD) Joint Department of Biomedical Engineering UNC Chapel Hill and NC State University UNC Chapel Hill Office 34 Glaxo Bldg UNC Chapel Hill Chapel Hill, NC 27599-7038 Phone: 919-966-0346 E-mail: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Homepage: http://www.med.unc.edu/wrkunits/2depts/physiolo/fac_reid.htm Primary Research Area:
Research Interests: Liver stem cells and lineage biology Education: University of North Carolina at Greensboro, 1963-65 About Dr. Lola M. Reid: Lola Reid was a professor in the Department of Molecular Pharmacology and in the Department of Immunology at the Albert Einstein College of Medicine, Bronx, New York, from 1977-1994. She moved to join the faculty at UNC in December, 1994. She has served on numerous editorial boards and grant study sections, has served as a consultant to many companies and for center grants at multiple institutions, and was a consultant to NASA on biological research in space. In 1995, she founded a company, Renaissance Cell Technologies, focused on clinical programs for liver cell therapies and commercial programs making use of liver lineage biology. The company was financed in 1997 by Incara Pharmaceuticals, Research Triangle Park, NC and in 2000 became a wholly owned subsidiary of Incara. In October, 2002, it was purchased by Toucan Capital, Bethesda, Maryland, to become an independent company, Vesta Therapeutics, dedicated to commercial and clinical programs leading to liver cell therapies and bioartificial organs. Recent Publications:
Date of Last Modification: 7/18/2006 Return To The Directory Modify Your Directory Entry | ||||||||||||||||||||||||||